Parameter estimation methodology in a model of hydrophobic drug release from a polymer coating

Journal of Controlled Release

Volumn 142, Issue 3, 2010, Pages 474-482

  Sirianni, Rachael W ^a   Jang, Eun Hyun ^b   Miller, Kathleen M ^b   Saltzman, W Mark ^a  

^a Yale University   (United States)

^b BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Controlled release; Hydrophobic; Mathematical model; Paclitaxel; Polymer

Indexed keywords

CONTROLLED RELEASE; CORONARY ARTERY STENT; DIFFERENT MECHANISMS; FICKIAN DIFFUSION; HYDROPHOBIC DRUG; HYDROPHOBIC POLYMERS; IN-VITRO; MATRIX; MECHANISTIC MODELS; OSMOTIC GRADIENTS; PACLITAXEL; PARAMETER COMBINATION; POLYMER COATING;

BUTENES; COMPUTER SIMULATION; DISSOLUTION; DRUG DOSAGE; HYDROPHOBICITY; PARAMETER ESTIMATION; PLASTIC COATINGS; STYRENE;

MATHEMATICAL MODELS;

PACLITAXEL; POLYMER;

ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CORONARY STENT; DIFFUSION; DISPERSION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHOBICITY; IN VITRO STUDY; INFORMATION PROCESSING; MATERIAL COATING; MATHEMATICAL MODEL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

COATED MATERIALS, BIOCOMPATIBLE; CORONARY STENOSIS; DRUG CARRIERS; DRUG-ELUTING STENTS; HUMANS; HYDROPHOBICITY; MICROSCOPY, ATOMIC FORCE; MODELS, BIOLOGICAL; OSMOSIS; PACLITAXEL; SOLUBILITY; STYRENES;

EID: 77349105738     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.11.021     Document Type: Article

References (34)

1. Herdeg C., Oberhoff M., and Karsch K.R. Antiproliferative stent coatings: taxol and related compounds. Semin. Interv. Cardiol. 3 (1998) 197-199
2. Kamath K.R., Barry J.J., and Miller K.M. The taxus drug-eluting stent: a new paradigm in controlled drug delivery. Adv. Drug Delivery Rev. 58 (2006) 412-436
3. Stone G.W., Ellis S.G., Cannon L., Mann J.T., Greenberg J.D., Spriggs D., O'Shaughnessy C.D., DeMaio S., Hall P., Popma J.J., Koglin J., and Russell M.E. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. J. Am. Med. Assoc. 294 (2005) 1215-1223
4. Ranade S.V., Miller K.M., Richard R.E., Chan A.K., Allen M.J., and Helmus M.N. Physical characterization of controlled release of paclitaxel from the taxus express drug-eluting stent. J. Biomed. Mater. Res., Part A. 71 (2004) 625-634
5. Chen J.-Z., Ranade S.V., and Xie X.-Q. NMR characterization of paclitaxel/poly (styrene-isobutylene-styrene) formulations. Int. J. Pharm. 305 (2005) 129-144
6. Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 52 (1963) 1145-1149
7. Costa P., and Sousa Lobo J.M. Modeling and comparison of dissolution profiles. European J. Pharm. Sci. 13 (2001) 123-133
8. Ritger P.L., and Peppas N.A. A simple equation for desciption of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Control. Release 5 (1987) 23-36
9. Siepmann J., Kranz H., Bodmeier R., and Peppas N.A. HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics. Pharm. Res. 16 (1999) 1748-1756
10. Harland R.S., Gazzaniga A., Sangalli M.E., Colombo P., and Peppas N.A. Drug/polymer matrix swelling and dissolution. Pharm. Res. 5 (1988) 488-494
11. Peppas N.A. Analysis of fickian and non-fickian drug release from polymers. Pharm. Acta Helv. 60 (1985) 110-111
12. Huang X., and Brazel C.S. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J. Control. Release 73 (2001) 121-136
13. Lee P.I. Novel approach to zero-order drug delivery via immobilized nonuniform drug distribution in glassy hydrogels. J. Pharm. Sci. 73 (1984) 1344-1347
14. Leuenberger H., Bonny J.D., and Kolb M. Percolation effects in matrix-type controlled drug release systems. Int. J. Pharm. 115 (1995) 217-224
15. Papadokostaki K.G., Polishchuk A.Y., and Petrou J.K. Modeling of solute release from polymeric monoliths subject to linear structural relaxation. J. Polym. Sci., Part B: Polym. Phys. 40 (2002) 1171-1188
16. Amsden B. A model for osmotic pressure driven release from cylindrical rubbery polymer matrices. J. Control. Release 93 (2003) 249-258
17. Varma M.V.S., Kaushal A.M., Garg A., and Garg S. Factors affecting mechanism and kinetics of drug release from matrix-based oral controlled drug delivery systems. Am. J. Drug Delivery 2 (2004) 43-57
18. Prabhu S., and Hossainy S. Modeling of degradation and drug release from a biodegradable stent coating. J. Biomed. Mater. Res., Part A 80 (2007) 732-741
19. Dua V. Controlled release of drugs from polymeric devices. Comp. Aided Chem. Eng. 24 (2007) 971-976
20. Abdekhodaie M.J., and Wu X.Y. Drug release from ion-exchange microspheres: mathematical modeling and experimental verification. Biomaterials 29 (2008) 1654-1663
21. Lindner W.D., Mockel J.E., and Lippold B.C. Controlled release of drugs from hydrocolloid embeddings. Pharmazie 51 (1996) 263-272
22. Csoka G., Dredan J., Marton S., Antal I., and Racz I. Evaluation of different mathematical methods describing drug liberation from new,'soft-patch' type matrix systems. Pharm. Dev. Technol. 4 (1999) 291-294
23. Zhang L., Long C., Pan J., and Qian Y. A dissolution-diffusion model and quantitative analysis of drug controlled release from biodegradable polymer microspheres. Can. J. Chem. Eng. 84 (2006) 558-566
24. Kang E., Wang H., Kwon I.K., Song Y.H., Kamath K., Miller K.M., Barry J., Cheng J.X., and Park K. Application of coherent anti-stokes raman scattering microscopy to image the changes in a paclitaxel-poly(styrene-b-isobutylene-b-styrene) matrix pre- and post-drug elution. J. Biomed. Mater. Res., Part A 87 (2008) 913-920
25. Sakharov D.V., Kalachev L.V., and Rijken D.C. Numerical simulation of local pharmacokinetics of a drug after intravascular delivery with an eluting stent. J. Drug Targeting 10 (2002) 507-513
26. Hwang C.W., Wu D., and Edelman E.R. Impact of transport and drug properties on the local pharmacology of drug-eluting stents. Int. J. Cardiovasc. Intervent. 5 (2003) 7-12
27. Zunino P. Multidimensional pharmacokinetic models applied to the design of drug-eluting stents. Cardiovasc. Eng. 4 (2004) 181-191
28. Balakrishnan B.S.B., Tzafriri A.R.P., Seifert P.M.S., Groothuis A.M.S., Rogers C.M.D., and Edelman E.R.M.D.P. Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents. Circulation 111 (2005) 2958-2965
29. Yang C., and Burt H.M. Drug-eluting stents: factors governing local pharmacokinetics. Adv. Drug Delivery Rev. 58 (2006) 402-411
30. Frenning G. Theoretical investigation of drug release from planar matrix systems: effects of a finite dissolution rate. J. Control. Release 92 (2003) 331-339
31. F. Alexis, S. S. Venkatraman, S. K. Rath, F. Boey, In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices, J. Control Release 98 (2004) 67-74.
32. Fung L., Ewend M.G., Sills A., Sipos E.P., Thompson R., Watts M., Colvin O.M., Brem H., and Saltzman W.M. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Res. 58 (1998) 672-684
33. Dunsmuir W., and Robinson P.M. Estimation of time-series models in the presence of missing data. J. Am. Stat. Assoc. 76 (1981) 560-568
34. Garnier H., and Wang L. Identification of continuous models from sampled data. first ed. (2008), Springer, New York